全文获取类型
收费全文 | 14857篇 |
免费 | 1429篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 136篇 |
儿科学 | 510篇 |
妇产科学 | 495篇 |
基础医学 | 1997篇 |
口腔科学 | 134篇 |
临床医学 | 2356篇 |
内科学 | 2468篇 |
皮肤病学 | 210篇 |
神经病学 | 1559篇 |
特种医学 | 224篇 |
外科学 | 1473篇 |
综合类 | 260篇 |
一般理论 | 27篇 |
预防医学 | 2144篇 |
眼科学 | 165篇 |
药学 | 928篇 |
中国医学 | 11篇 |
肿瘤学 | 1214篇 |
出版年
2024年 | 19篇 |
2023年 | 134篇 |
2022年 | 243篇 |
2021年 | 485篇 |
2020年 | 299篇 |
2019年 | 506篇 |
2018年 | 562篇 |
2017年 | 411篇 |
2016年 | 446篇 |
2015年 | 467篇 |
2014年 | 641篇 |
2013年 | 866篇 |
2012年 | 1274篇 |
2011年 | 1352篇 |
2010年 | 680篇 |
2009年 | 605篇 |
2008年 | 1025篇 |
2007年 | 1032篇 |
2006年 | 1046篇 |
2005年 | 1047篇 |
2004年 | 779篇 |
2003年 | 692篇 |
2002年 | 617篇 |
2001年 | 95篇 |
2000年 | 94篇 |
1999年 | 90篇 |
1998年 | 113篇 |
1997年 | 76篇 |
1996年 | 54篇 |
1995年 | 53篇 |
1994年 | 53篇 |
1993年 | 40篇 |
1992年 | 32篇 |
1991年 | 24篇 |
1990年 | 28篇 |
1989年 | 32篇 |
1988年 | 19篇 |
1987年 | 23篇 |
1986年 | 20篇 |
1985年 | 21篇 |
1984年 | 19篇 |
1982年 | 16篇 |
1981年 | 12篇 |
1980年 | 19篇 |
1979年 | 13篇 |
1978年 | 13篇 |
1973年 | 11篇 |
1972年 | 12篇 |
1971年 | 12篇 |
1969年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
132.
D G Scott M Salmon D L Scott A Blann P A Bacon K W Walton C D Oakland G F Slaney 《Clinical rheumatology》1986,5(4):517-522
Takayasu's arteritis is an inflammatory panarteritis of unknown aetiology affecting large elastic arteries. We examined a segment of abnormal common carotid artery removed at by-pass surgery from a 23-year-old man with typical angiographic features of Takayasu's arteritis. Using monoclonal antibodies we were able to demonstrate marked infiltration of the arterial wall with OKT8 positive lymphocytes (suppressor/cytotoxic cells) but not with OKT4 positive lymphocytes (helper cells). Studies of circulating lymphocytes showed increased numbers of "activated" cells and increased in vitro cytotoxicity against cultured human umbilical cord endothelial cells, compared to normal lymphocytes. Cellular immunological mechanisms may play an important role in the pathogenesis of Takayasu's arteritis, possibly through the direct action of cytotoxic T cells on large elastic arteries. 相似文献
133.
Kallen Michael A. Brown Heather E. Hatton Joeffrey R. Doyle William A. Murphy Ryan Elliott Ryan Gutierrez Mark A. Catherwood Emma L. Pitman Heather P. Liu Vincent X. Gershon Richard C. 《Quality of life research》2022,31(7):2201-2212
Quality of Life Research - To develop two item content-matched, precise, score-level targeted inpatient physical function (PF) short form (SF) measures: one clinician-reported, one... 相似文献
134.
Diabetes is the seventh leading cause of death in United States. Dietary intake and behaviors are essential components of diabetes management. Growing evidence suggests dietary components beyond carbohydrates may critically impact glycemic control. Assessment tools on mobile platforms have the ability to capture multiple aspects of dietary behavior in real-time throughout the day to inform and improve diabetes management and insulin dosing. The objective of this narrative review was to summarize evidence related to dietary behaviors and composition to inform a mobile image-based dietary assessment tool for managing glycemic control of both diabetes types (type 1 and type 2 diabetes). This review investigated the following topics amongst those with diabetes: (1) the role of time of eating occasion on indicators of glycemic control; and (2) the role of macronutrient composition of meals on indicators of glycemic control. A search for articles published after 2000 was completed in PubMed with the following sets of keywords “diabetes/diabetes management/diabetes prevention/diabetes risk”, “dietary behavior/eating patterns/temporal/meal timing/meal frequency”, and “macronutrient composition/glycemic index”. Results showed eating behaviors and meal macronutrient composition may affect glycemic control. Specifically, breakfast skipping, late eating and frequent meal consumption might be associated with poor glycemic control while macronutrient composition and order of the meal could also affect glycemic control. These factors should be considered in designing a dietary assessment tool, which may optimize diabetes management to reduce the burden of this disease. 相似文献
135.
Jabulani R. Ncayiyana Leonardo Martinez Elizabeth Goddard Landon Myer Heather J. Zar 《Nutrients》2021,13(5)
Early-life vitamin D deficiency is associated with adverse child health outcomes, but the prevalence of vitamin D deficiency and its correlates in infants remains underexplored, particularly in sub-Saharan Africa. We aimed to investigate the prevalence of vitamin D deficiency and its correlates among young infants in South Africa. This study included 744 infants, aged 6–10 weeks from the Drakenstein Child Health Study, a population-based birth cohort. Infants were categorized into distinct categories based on serum 25(OH)D concentration level including deficient (<50 nmol/L), insufficient (50–74 nmol/L), and sufficient (≥75 nmol/L). Using multivariable Tobit and logistic regression models, we examined the correlates of serum 25(OH)D3 levels. The overall prevalence of vitamin D deficiency was 81% (95% confidence intervals (CI]) 78–83). Multivariable regression analysis showed that serum 25(OH)D3 concentration was independently associated with study site, socioeconomic status, and sex. Birth in winter and breastfeeding were the strongest predictors of lower serum 25(OH)D3 concentration levels. Compared to non-breastfed children, children breastfed were at higher risk of vitamin D deficiency (AOR, 1.96; 95% CI, 1.04–3.67) and breastfeeding for more than one month was associated with greater likelihood of vitamin D deficiency (AOR, 5.40; 95% CI, 2.37–12.32) and lower vitamin D concentrations (−16.22 nmol/L; 95% CI, −21.06, −11.39). Vitamin D deficiency in infants is ubiquitous, under-recognised, and strongly associated with season of birth and breastfeeding in this setting. Nutritional interventions with vitamin D supplementation in national health programs in low- and middle-income countries are urgently needed to improve early-life vitamin D status in infants. 相似文献
136.
Ashford Kristin McCubbin Andrea Barnett Janine Blair Lisa M. Lei Feitong Bush Heather Breland Alison 《Maternal and child health journal》2021,25(8):1175-1181
Maternal and Child Health Journal - In the US, approximately 8% of pregnant women smoke, and 5–11.9% currently use ENDS products. The health effects of ENDS use are debated; however, most... 相似文献
137.
Armstrong-Heimsoth Amy Hahn-Floyd Molly Williamson Heather J. Kurka Jonathan M. Yoo Wonsuk Rodríguez De Jesús Sue A. 《The journal of behavioral health services & research》2021,48(2):287-305
The Journal of Behavioral Health Services & Research - Youth aging out of the foster care system have well-documented challenges when transitioning to adulthood. Multiple transition services... 相似文献
138.
Molly E. Baumann Danielle M. DeBruler Britani N. Blackstone Rebecca A. Coffey Steven T. Boyce Dorothy M. Supp J. Kevin Bailey Heather M. Powell 《Burns : journal of the International Society for Burn Injuries》2021,47(2):466-478
IntroductionDetermining the efficacy of anti-scar technologies can be difficult as qualitative, subjective assessments are often utilized instead of systematic, objective measures. Perceptions regarding the reliability of instruments for quantitative measurements along with their high cost and increased data collection time may discourage their use, leading to use of scar scales which are relatively quick and low-cost. To directly evaluate the reliability of instruments for quantitative measurements of scar properties, instruments and two qualitative scales were compared by assessing a variety of cutaneous scars.MethodsScar height and surface texture were evaluated using a 3D scanner and a mold/cast technique. Scar color was evaluated by using a spectroscopy-based tool, the Mexameter®, and digital photography with image analysis. Scar biomechanics were evaluated using the BTC-2000?, Dermal Torque Meter (DTM®), and ballistometer®. The Vancouver Scar Scale (VSS) and Patient and Observer Scar Assessment Scale (POSAS) were used to qualitatively evaluate the same scar properties. Intraclass correlation coefficients (ICC) were used to determine inter- and intra-user reliability (poor, moderate, good, excellent) with all instruments and the kappa reliability statistic was used to asses inter-user reliability (poor, fair, moderate, good, very good) for VSS and POSAS. Time for measurement collection and after collection analysis was also recorded.ResultsThe Mexameter® was the most reliable method for evaluating erythema and pigmentation compared to digital photography and image processing, POSAS and VSS. Digital photography and analysis was more reliable than POSAS and VSS. Assessment of scar height was significantly more reliable when using a 3D scanner versus VSS and POSAS. The 3D scanner and mold-cast techniques also offered an additional benefit of providing an absolute value of scar height relative to the surrounding tissue. Intra-user reliability for all mechanical tests was moderate to good. Inter-user reliability was greater when using the BTC-2000? and ballistometer® versus the DTM®. All quantitative measurements took less than 90 s for collection, with the exception of the mold/cast technique.ConclusionNon-invasive instruments allow scar properties to be quantitatively assessed with high sensitivity and as a function of time and/or treatment without the need for biopsy collection. Overall, the reliability of scar assessments was significantly improved when quantitative instruments were utilized versus scar scales. Quantitative assessment of color and biomechanics were swift, requiring less than 90 s per measurement while assessments of texture and height required additional analysis time after collection. With proper training of clinical staff and well-defined protocols for measurement collection, reliable, quantitative assessments of scar properties can be collected with little disruption to the clinical workflow. 相似文献
139.
140.
Mariah Farrell Heather Fairfield Samantha Costa Anastasia D'Amico Carolyne Falank Daniel J Brooks Michaela R Reagan 《Journal of bone and mineral research》2021,36(1):158-169
Obesity, a growing pandemic, is a risk factor for many cancers and causes increased bone marrow adipose tissue (BMAT). in vitro studies and obese animal models suggest that BMAT contributes to cancer progression, but there is a lack of preclinical models to directly test BMAT's role in cancer. Overactivation of peroxisome-proliferator-activated receptor-γ (PPARγ) can skew bone formation and resorption rates, resulting in increased BMAT and trabecular bone loss. Thiazolidinediones (eg, rosiglitazone) are anti-diabetic therapies that promote adipogenesis through PPARγ activation. We investigated if rosiglitazone increases BMAT in an immunocompromised model, commonly used in cancer research, and if these effects could be reversed by co-administering a bone anabolic agent (sclerostin-neutralizing antibody [Scl-Ab]), which has been shown to inhibit adipogenesis, using DXA, μCT, OsO4 μCT, and dynamic histomorphometry. Four weeks of rosiglitazone in female SCID Beige mice (cohort 1) significantly decreased trabecular bone volume (BV/TV) by about one-half, through increased osteoclast and suppressed osteoblast activity, and significantly increased BMAT. In cohort 2, mice were administered rosiglitazone ± Scl-Ab for 4 weeks, and then rosiglitazone was discontinued and Scl-Ab or vehicle were continued for 6 weeks. Scl-Ab significantly increased bone parameters (eg, BV/TV, N.Ob/B.Pm, and MS/BS) in both groups. Scl-Ab also overcame many negative effects of rosiglitazone (eg, effects on trabecular bone parameters, increased mineralization lag time [MLT], and decreased bone formation rate [BFR]). Interestingly, Scl-Ab significantly decreased rosiglitazone-induced BMAT in the femur, mostly due to a reduction in adipocyte size, but had a much weaker effect on tibial BMAT. These data suggest targeting sclerostin can prevent rosiglitazone-induced bone loss and reduce BM adiposity, in some, but not all BMAT locations. Collectively, our data demonstrate that rosiglitazone increases BMAT in SCID Beige mice, but concomitant changes in bone may confound its use to specifically determine BMAT's role in tumor models. © 2020 American Society for Bone and Mineral Research (ASBMR). 相似文献